Amneal Pharmaceuticals, Inc. clinical trials

The registry lists 45 studies whose lead sponsor is Amneal Pharmaceuticals, Inc. or one of 4 companies grouped under it. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 12, 2026.

Studies

Recruiting first, then most recently updated. Showing 45 of 45.

• Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female VolunteersRecruitingNCT06995482Phase 1

  Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.

• A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseaseRecruitingNCT06765668Phase 4

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted after Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both EyesRecruitingNCT06267274Phase 1

  Sponsor listed in the registry: Amneal Pharmaceuticals, LLC

• Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.RecruitingNCT05401357Phase 3

  Sponsor listed in the registry: Amneal Pharmaceuticals, LLC

• Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy SubjectsCompletedNCT06929039Phase 1

  Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.

• A Comparative Evaluation of Pharmacokinetics and Immunogenicity.CompletedNCT06918587Phase 1

  Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.

• A Comparative Pharmacokinetic Study of ADL-018 Autoinjector Compared to A Pre-filled Syringe in Healthy Subjects.CompletedNCT06929052Phase 1

  Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.

• SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of AMN1126 in Healthy Post-Menopausal FemalesCompletedNCT06467201Phase 1

  Sponsor listed in the registry: Amneal Pharmaceuticals, LLC

• Pharmacokinetic, Immunogenicity, and Safety Evaluation of Pegfilgrastim TPI-120 in Healthy AdultsCompletedNCT07416955Phase 1

  Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.

• Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic UrticariaCompletedNCT05774639Phase 3

  Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.

• PK, PD, Safety & Immunogenicity of ADL-018 Lyo in Healthy Adult SubjectsCompletedNCT05564611Phase 1

  Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.

• Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in AdolescentsCompletedNCT00617695Phase 3

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• A TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy SubjectsCompletedNCT06161220Phase 1

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted after Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• Open Label, Sequential Dosing , Single Ascending Dose and Multiple Dose Safety Tolerability and Pharmacokinetic StudyCompletedNCT06074757Phase 1

  Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.

• Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor FluctuationsCompletedNCT03877510Phase 3

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted after Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• To Compare the PK, PD, Safety & Immunogenicity of ADL-018 in Healthy SubjectsCompletedNCT05413161Phase 1

  Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.

• A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor FluctuationsCompletedNCT03670953Phase 3

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted after Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's DiseaseCompletedNCT03007888Phase 2

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the KneeCompletedNCT02121002Phase 3

  Sponsor listed in the registry: Amneal Pharmaceuticals, LLC

• Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLECompletedNCT03275922Phase 3

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).CompletedNCT00974974Phase 3

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation AerosolTerminatedNCT03562949Phase 3

  Sponsor listed in the registry: Amneal Ireland Limited

• A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-LevodopaCompletedNCT00869791Phase 2

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's DiseaseCompletedNCT01096186Phase 3

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety StudyCompletedNCT01411137Phase 3

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• IPX056 in Subjects With Established Spasticity Resulting From Multiple SclerosisCompletedNCT00488839Phase 3

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's DiseaseCompletedNCT02271503Phase 2

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• A Study With IPX056 in Subjects With Spasticity Associated With Multiple SclerosisCompletedNCT00914290Phase 2

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's DiseaseCompletedNCT00880620Phase 3

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's DiseaseCompletedNCT00279825Phase 2

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's DiseaseCompletedNCT00239564Phase 1/2

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's DiseaseCompletedNCT00253084Phase 2

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066CompletedNCT01130493Phase 3

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50Status unknownNCT03562923Phase 3

  Sponsor listed in the registry: Amneal Ireland Limited

• Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg BaseStatus unknownNCT03549897Phase 3

  Sponsor listed in the registry: Amneal Ireland Limited

• Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)CompletedNCT01521663Phase 2

  Sponsor listed in the registry: Impax Laboratories, LLC · First submitted before Impax Laboratories, LLC became part of Amneal Pharmaceuticals, Inc.

• BE Study in Patients - Methotrexate TabletsStatus unknownNCT02940561Phase 1

  Sponsor listed in the registry: Amneal Pharmaceuticals, LLC

• Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic RhinitisCompletedNCT02125253Phase 3

  Sponsor listed in the registry: Amneal Pharmaceuticals, LLC

• Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed ConditionsCompletedNCT02103322Phase 2/3

  Sponsor listed in the registry: Amneal Pharmaceuticals, LLC

• Bioequivalence Fasting Study in PatientsCompletedNCT02072954Phase 2/3

  Sponsor listed in the registry: Amneal Pharmaceuticals, LLC

• Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting ConditionsCompletedNCT02110368Phase 3

  Sponsor listed in the registry: Amneal Pharmaceuticals, LLC

• Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)CompletedNCT01650051Phase 3

  Sponsor listed in the registry: Amneal Pharmaceuticals, LLC

• Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to PlaceboCompletedNCT01779947Phase 3

  Sponsor listed in the registry: Amneal Pharmaceuticals, LLC

• Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. PlaceboCompletedNCT01064024Phase 3

  Sponsor listed in the registry: Amneal Pharmaceuticals, LLC

• Minocycline HCl Extended Release Tablets 135 mg Oral Bioequivalence StudyCompletedNCT01067001

  Sponsor listed in the registry: Amneal Pharmaceuticals Co. India Private Limited